Empirical tuberculosis treatment in African infants living with HIV hospitalised with severe pneumonia: a phase 2/3 randomized factorial controlled superiority trial.

Oral step-down, optimal drug and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia: a factorial randomised controlled trial

Background

World Health Organization (WHO) recommends five days intravenous (IV)

Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial).

There is a need for effective therapy for COVID-19 pneumonia. Convalescent plasma has antiviral acti

A Cluster Randomized Controlled Trial Evaluating the Efficacy of Peer Mentors to Support South African Women Living with HIV and Their Infants

A randomised controlled trial of 3 strategies for the treatment of ART-naive HIV infected patients with tuberculosis v1

Tuberculosis (TB) is the leading cause of mortality among people with Human Immunodeficiency Virus (

Cytokine profile and clinical correlates in HIV-exposed infants with severe (hypoxic) pneumonia

Introduction. Severe pneumonia in infants who are HIV-infected

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial

Background BCG vaccination provides incomplete protection against tuberculosis in infants. A new vac